There's a quiet fear that arrives somewhere in your sixties. Not of the big diagnoses—of the small things. The name on the tip of your tongue. The reason you walked into the room. The word that used to come instantly and now takes a beat too long.

Most lion's mane research lives in petri dishes and mouse cages. Fascinating, but abstract—easy to wave away as "that's not people." So the honest question has always been the hard one: what happens when you give erinacine A to actual humans and measure them?

In 2024, a research team at the University of Primorska in Slovenia did exactly that, and published it in the Journal of Functional Foods. It's the kind of study we look for before we stand behind an ingredient—because ErinaPrime™ is built on erinacine A, and human data is the standard that matters.

The Study: A Real Trial, Real People

This was a randomized, double-blind, placebo-controlled pilot study (ClinicalTrials.gov NCT04939961)—the design built specifically to remove wishful thinking. Thirty-three older adults were randomly assigned to either an erinacine A-enriched Hericium erinaceus group or a matched placebo group, for eight weeks. Neither the participants nor the researchers knew who got what until the data was in.

Before and after, the team measured cognitive performance using two non-verbal processing-speed tests, alongside blood markers and stool samples for the gut microbiome.

What They Observed

• Faster cognitive processing speed. The supplemented group showed a significant improvement in cognitive ability—specifically the speed of basic cognitive operations—when baseline scores, age, gender, and a marker called CHI3L1 were accounted for.
• Movement in BDNF. The researchers reported clear effects on circulating levels of Brain-Derived Neurotrophic Factor (BDNF), a protein involved in the health and maintenance of neurons.
• A more diverse gut microbiome. The supplemented group showed a significant increase in gut-microbiota diversity, which positively correlated with levels of Neuropeptide Y (NPY).
• Safe and well-tolerated. The authors described the supplementation as a safe, well-tolerated intervention over the study period.

One mechanistic thread the researchers raised is worth noting: the gut enzyme CHI3L1 may influence how well the mushroom's bioactive compounds are absorbed—a reminder that the brain and the gut are not separate conversations.

Why This Is the Study Behind ErinaPrime

Cell studies tell you a compound can do something. Mouse studies tell you it does something in a living system. But a randomized, placebo-controlled human trial is a different order of evidence—it's people, blinded, measured, compared against placebo.

And note what was tested: not a generic "mushroom powder," but an erinacine A-enriched preparation. That is the entire premise of ErinaPrime™, standardized to 10 mg of erinacine A per gram and formulated without hericenones. We specify the molecule the human research actually used—because "lion's mane" on a label tells you the genus, not the dose of the compound that was studied.

It is the same discipline behind every active in NeuraLegend™: chosen by form, specified by compound, sourced with intent, never from China.

The Honest Frame

Keep this in proportion: it was a pilot study of 33 participants over eight weeks. A pilot is designed to detect a signal and justify larger trials—it is a promising beginning, not a final word, and its findings need confirmation in bigger, longer studies. It measured an erinacine A-enriched mushroom preparation, which is related to but not identical to any specific finished product, and it looked at cognitive performance in generally healthy aging—not the treatment of any medical condition.

We share it because it does something most supplement science never gets to: it puts the ingredient in front of real people, blinds the test, and measures what comes back. That word on the tip of your tongue? Science is finally asking the right question about it.

Reference: Effect of erinacine A-enriched Hericium erinaceus supplementation on cognition: A randomized, double-blind, placebo-controlled pilot study. Journal of Functional Foods. 2024;115:106120. University of Primorska, Slovenia. ClinicalTrials.gov: NCT04939961. doi:10.1016/j.jff.2024.106120.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article summarizes a small pilot study for educational purposes only and does not describe the effects of any specific dietary supplement; it does not constitute medical advice. Individual results may vary. Consult your healthcare provider before beginning any supplement, particularly if you are pregnant, nursing, taking medication, or managing a health condition.